Is There a Correlation Between Brain Naturietic Peptide Levels and Echocardiographic and Hemodynamic Parameters in Heart Transplant Patients?

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2534-2536

  Almenar, L ^a   Arnau, M A ^a   Martinez Dolz L ^a   Hervas I ^a   Osa, A ^a   Miro V ^a   Sanchez E ^a   Zorio, E ^a   Rueda, J ^a   Mateo, A ^a   Salvador, A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE RELAXATION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE PRESSURE; HEART TRANSPLANTATION; HEART VENTRICLE CONTRACTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE SIZE; HEMODYNAMIC PARAMETERS; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REOPERATION;

BIOLOGICAL MARKERS; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; HEART TRANSPLANTATION; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PATIENT SELECTION;

EID: 33750614138     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.082     Document Type: Article

References (9)

1. Silver M.A., Maisel A., Yancy C.W., et al. BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Heart Fail 10 suppl 3 (2004) 1
2. Lubien E., DeMaria A., Krishnaswamy P., et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. Circulation 105 (2002) 595
3. Dokainish H., Zoghbi W., Lakkis N., et al. Optimal non-invasive assessment of left ventricular filling pressures. A comparison of tissue doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109 (2004) 2432
4. Yancy C.W. Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the Follow-Up Serial Infusion of Nesiritide (FUSION) trial. Heart Fail Rev 9 (2004) 209
5. Arnau M.A., Almenar L., Hervás I., et al. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant 23 (2004) 850
6. O'Neill J.O., McRae A.T., Troughton R.W., et al. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant 24 (2005) 416
7. Hervas I., Almenar L., Pérez-Pastor J.L., et al. Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determinations and biopsy grading of rejection. Nucl Med Commun 24 (2003) 925
8. Mehra M.R., Uber P.A., Potluri S., et al. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol 94 (2004) 454
9. Stengel S.M., Allemann Y., Zimmerli M., et al. Doppler tissue imaging for assessing left ventricular diastolic dysfunction in heart transplant rejection. Heart 86 (2001) 432